Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02612194
Title LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Earle Burgess
Age Groups: adult
Covered Countries USA

No variant requirements are available.